Citations
1. Gadzik J. (2006). "How much should I weigh?"--Quetelet's equation, upper weight limits, and BMI prime. Connecticut medicine, 70(2), 81–88.
2. Pai, M. P., & Paloucek, F. P. (2000). The origin of the "ideal" body weight equations. The Annals of pharmacotherapy, 34(9), 1066–1069.
3. Techanivate, A., Kumwilaisak, K., & Samranrean, S. (2005). Estimation of the proper length of orotracheal intubation by Chula formula. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 88(12), 1838–1846.
4. Acute Respiratory Distress Syndrome Network, Brower, R. G., Matthay, M. A., Morris, A., Schoenfeld, D., Thompson, B. T., & Wheeler, A. (2000). Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The New England journal of medicine, 342(18), 1301–1308.
5. Gross J. B. (1983). Estimating allowable blood loss: corrected for dilution. Anesthesiology, 58(3), 277–280.
6. Corcoran, T., Rhodes, J. E., Clarke, S., Myles, P. S., & Ho, K. M. (2012). Perioperative fluid management strategies in major surgery: a stratified meta-analysis. Anesthesia and analgesia, 114(3), 640–651.
7. Giglio, M. T., Marucci, M., Testini, M., & Brienza, N. (2009). Goal-directed haemodynamic therapy and gastrointestinal complications in major surgery: a meta-analysis of randomized controlled trials. British journal of anaesthesia, 103(5), 637–646.
8. Noblett, S. E., Snowden, C. P., Shenton, B. K., & Horgan, A. F. (2006). Randomized clinical trial assessing the effect of Doppler-optimized fluid management on outcome after elective colorectal resection. The British journal of surgery, 93(9), 1069–1076.
9. Nisanevich, V., Felsenstein, I., Almogy, G., Weissman, C., Einav, S., & Matot, I. (2005). Effect of intraoperative fluid management on outcome after intraabdominal surgery. Anesthesiology, 103(1), 25–32.
10. Shaw, A. D., Bagshaw, S. M., Goldstein, S. L., Scherer, L. A., Duan, M., Schermer, C. R., & Kellum, J. A. (2012). Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Annals of surgery, 255(5), 821–829.
11. Maitland, K., Kiguli, S., Opoka, R. O., Engoru, C., Olupot-Olupot, P., Akech, S. O., Nyeko, R., Mtove, G., Reyburn, H., Lang, T., Brent, B., Evans, J. A., Tibenderana, J. K., Crawley, J., Russell, E. C., Levin, M., Babiker, A. G., Gibb, D. M., & FEAST Trial Group (2011). Mortality after fluid bolus in African children with severe infection. The New England journal of medicine, 364(26), 2483–2495.
12. Urman, R. D., & Ehrenfeld, J. M. (Eds.). (2021). Pocket Anesthesia (Fourth Edition). Wolters Kluwer.
13. Folino TB, Muco E, Safadi AO, et al. Propofol. [Updated 2023 Jul 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
14. Williams LM, Boyd KL, Fitzgerald BM. Etomidate. [Updated 2023 Jun 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
15. Rosenbaum SB, Gupta V, Patel P, et al. Ketamine. [Updated 2024 Jan 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
16. Williams LM, Boyd KL, Fitzgerald BM. Etomidate. [Updated 2023 Jun 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
17. Williams LM, Boyd KL, Fitzgerald BM. Etomidate. [Updated 2023 Jun 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
18. Williams LM, Boyd KL, Fitzgerald BM. Etomidate. [Updated 2023 Jun 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
19. Syed Q, Kohli A. Methohexital. [Updated 2023 Jul 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
20. Skibiski J, Patel P, Abdijadid S. Barbiturates. [Updated 2024 Jan 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
21. Reel B, Maani CV. Dexmedetomidine. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
22. Forrest, J. A., Clements, J. A., & Prescott, L. F. (1982). Clinical pharmacokinetics of paracetamol. Clinical pharmacokinetics, 7(2), 93–107.
23. Hospira, Inc. Fentanyl Citrate Injection [package insert]. Lake Forest, IL: Hospira, Inc. 2023.
24. Abbott Laboratories. Ultiva Injection [package insert]. North Chicago, IL: Abbott Laboratories. 2001.
25. Hospira, Inc. Sufentanil Citrate Injection [package insert]. Lake Forest, IL: Hospira Inc. 2024.
26. Akorn, Inc. Alfentanil HCL Injection [package insert]. Lake Forest, IL: Akorn, Inc. 2016.
27. Hospira, Inc. Morphine sulfate Injection [package insert]. Lake Forest, IL: Hospira, Inc. 2023.
28. Hospira, Inc. Hydromorphone Hydrochloride Injection [package insert]. Lake Forest, IL: Hospira, Inc. 2023.
29. Hospira, Inc. Demerol Injection [package insert]. Lake Forest, IL: Hospira, Inc. 2019
30. Hospira, Inc. Ketorolac Tromethamine Injection [package insert]. Lake Forest, IL: Hospira, Inc. 2014.
31. Davies N. M. (1998). Clinical pharmacokinetics of ibuprofen. The first 30 years. Clinical pharmacokinetics, 34(2), 101–154.
32. Hospira, Inc. Midazolam Hydrochloride Injection [package insert]. Lake Forest, IL: Hospira, Inc. 2023.
33. Hikma Pharmaceuticals USA, Inc. Lorazepam Injection [package insert]. Berkeley Heights, NJ: Hikma Pharmaceuticals USA, Inc. 2021.
34. Hospira, Inc. Diazepam Injection [package insert]. Lake Forest, IL: Hospira, Inc. 2023.
35. Hospira, Inc. Propofol Injection [package insert]. Lake Forest, IL: Hospira, Inc. 2023.
36. Hospira, Inc. Amidate (Etomidate) Inection [package insert]. Lake Forest, IL: Hospira, Inc. 2017.
37. Hospira, Inc. Ketamine Hydrochloride Injection [package insert]. Lake Forest, IL: Hospira, Inc. 2024.
38. Par Pharmaceutical. Brevital Injection [package insert]. Chestnut Ridge, NY: Par Pharmaceutical. 2017.
39. Hospira, Inc. Precedex (dexmedetomidine) Injection [package insert]. Lake Forest, IL: Hospira, Inc. 2013.
40. Merck & Co., Inc. Bridion (Sugammadex) Injection [package insert]. Whitehouse Station, NJ: Merck & Co., Inc. 2015.
41. Fresenius Kabi USA, LLC. Nesacaine (Chlorprocaine HCl) Injection [package insert]. Lake Zurich, IL: Fresenius Kabi USA, LLC. 2018.
42. Tonder S, Togioka BM, Maani CV. Chloroprocaine. [Updated 2023 Jul 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
43. Richards JR, Laurin EG. Cocaine. [Updated 2023 Jun 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
44. Sheikh NK, Dua A. Procaine. [Updated 2023 May 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
45. Stringer CM, Lopez MJ, Maani CV. Tetracaine. [Updated 2023 Aug 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
46. Shafiei FT, McAllister RK, Lopez J. Bupivacaine. [Updated 2023 Aug 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
47. Hospira, Inc. Bupivacaine Hydrochloride Injection [package insert]. Lake Forest, IL: Hospira, Inc. 2009.
48. APP Pharmaceuticals, LLC. Xylocaine (Lidocaine HCl) Injection [package insert]. Schaumburg, IL: APP Pharmaceuticals. 2010.
49. Beecham GB, Nessel TA, Goyal A. Lidocaine. [Updated 2024 Aug 16]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
50. Hospira, Inc. Carbocaine (Mepivacaine Hydrochloride) Injection [package insert]. Lake Forest, IL: Hospira, Inc. 2023.
51. Becker, D. E., & Reed, K. L. (2006). Essentials of local anesthetic pharmacology. Anesthesia progress, 53(3), 98–110.
52. Fresenius Kabi USA, LLC. Naropin (Ropivacaine HCl) Injection [package insert]. Lake Zurich, IL: Fresenius Kabi USA, LLC. 2018.
53. Tetzlaff, J. E. (2009). Local anesthesia. In S. A. Waldman, A. Terzic, L. J. Egan, J.-L. Elghozi, A. Jahangir, G. C. Kane, W. K. Kraft, L. D. Lewis, J. D. Morrow, L. V. Zingman, D. R. Abernethy, A. J. Atkinson, N. L. Benowitz, D. C. Brater, J. Gray, P. K. Honig, G. L. Kearns, B. A. Levey, S. P. Spielberg, R. Weinshilboum, & R. L. Woosley (Eds.), Pharmacology and therapeutics (pp. 863-872). W.B. Saunders.
54. Katari, N. K., & Jonnalagadda, S. B. (2022). Prilocaine: Mechanisms and application. In R. Rajendram, V. B. Patel, V. R. Preedy, & C. R. Martin (Eds.), Treatments, mechanisms, and adverse reactions of anesthetics and analgesics (pp. 151-164). Academic Press.
55. Hospira, Inc. Quelicin (Succinylcholine Chloride) Injection [package insert]. Lake Forest, IL: Hospira, Inc. 2022.
56. Hospira, Inc. Rocuronium Bromide Injection [package insert]. Lake Forest, IL: Hospira, Inc. 2019.
57. Hospira, Inc. Vecuronium Bromide Injection [package insert]. Lake Forest, IL: Hospira, Inc. 2018.
58. Hospira, Inc. Pancuronium Bromide Injection [package insert]. Lake Forest, IL: Hospira, Inc. 2019.
59. Hospira, Inc. Atracurium Besylate Injection [package insert]. Lake Forest, IL: Hospira, Inc. 2021.
60. Hospira, Inc. Cisatracurium Besylate Injection [package insert]. Lake Forest, IL: Hospira, Inc. 2023.
61. Engbaek, J., Ording, H., Ostergaard, D., & Viby-Mogensen, J. (1985). Edrophonium and neostigmine for reversal of the neuromuscular blocking effect of vecuronium. Acta anaesthesiologica Scandinavica, 29(5), 544–546.
62. Fresenius Kabi USA, LLC. Neostigmine Methylsulfate Injection [package insert]. Lake Zurich, IL: Fresenius Kabi USA, LLC. 2020.
63. Sandoz Inc. Regonol (Pyridostigmine Bromide Injection) [package insert]. Princeton, NJ: Sandoz Inc. 2021.
64. American Society of Anesthesiologists. (2020). ASA physical status classification system.
65. Abouleish AE, Leib ML, Cohen NH. ASA provides examples to each ASA physical status class. ASA Monitor 2015; 79:38-9.
66. Mallampati, S. R., Gatt, S. P., Gugino, L. D., Desai, S. P., Waraksa, B., Freiberger, D., & Liu, P. L. (1985). A clinical sign to predict difficult tracheal intubation: a prospective study. Canadian Anaesthetists' Society journal, 32(4), 429–434.
67. Samsoon, G. L., & Young, J. R. (1987). Difficult tracheal intubation: a retrospective study. Anaesthesia, 42(5), 487–490.
68. Lee, A., Fan, L. T., Gin, T., Karmakar, M. K., & Ngan Kee, W. D. (2006). A systematic review (meta-analysis) of the accuracy of the Mallampati tests to predict the difficult airway. Anesthesia and analgesia, 102(6), 1867–1878.
69. Practice Guidelines for Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration: Application to Healthy Patients Undergoing Elective Procedures: An Updated Report by the American Society of Anesthesiologists Task Force on Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration. (2017). Anesthesiology, 126(3), 376–393.
70. Nørskov, A. K., Rosenstock, C. V., Wetterslev, J., & Lundstrøm, L. H. (2013). Incidence of unanticipated difficult airway using an objective airway score versus a standard clinical airway assessment: the DIFFICAIR trial - trial protocol for a cluster randomized clinical trial. Trials, 14, 347.
71. Nørskov, A. K., Wetterslev, J., Rosenstock, C. V., Afshari, A., Astrup, G., Jakobsen, J. C., Thomsen, J. L., Bøttger, M., Ellekvist, M., Schousboe, B. M., Horn, A., Jørgensen, B. G., Lorentzen, K., Madsen, M. H., Knudsen, J. S., Thisted, B. K., Estrup, S., Mieritz, H. B., Klesse, T., Martinussen, H. J., … Lundstrøm, L. H. (2016). Effects of using the simplified airway risk index vs usual airway assessment on unanticipated difficult tracheal intubation - a cluster randomized trial with 64,273 participants. British journal of anaesthesia, 116(5), 680–689.
72. Siddiqui BA, Kim PY. Anesthesia Stages. [Updated 2023 Jan 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
73. Bratzler, D. W., Dellinger, E. P., Olsen, K. M., Perl, T. M., Auwaerter, P. G., Bolon, M. K., Fish, D. N., Napolitano, L. M., Sawyer, R. G., Slain, D., Steinberg, J. P., Weinstein, R. A., American Society of Health-System Pharmacists, Infectious Disease Society of America, Surgical Infection Society, & Society for Healthcare Epidemiology of America (2013). Clinical practice guidelines for antimicrobial prophylaxis in surgery. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 70(3), 195–283.
74. Committee on Quality Management and Departmental Administration, American Society of Anesthesiologists. Statement on Continuum of Depth of Sedation: Definition of General Anesthesia and Levels of Sedation/Analgesia. (2019, October 23).
75. Finfer, S., Myburgh, J., & Bellomo, R. (2018). Intravenous fluid therapy in critically ill adults. Nature reviews. Nephrology, 14(9), 541–557.
76. Barash, P. G., Cullen, B. F., Stoelting, R. K., Cahalan, M. K., Stock, M. C., Ortega, R., Sharar, S. R., & Holt, N. F. (2017). Clinical anesthesia (8th ed., p. 461). Wolters Kluwer.
77. Baxter Healthcare Corporation. Sevoflurane Liquid for Inhalation [package insert]. Deerfield, IL: Baxter Healthcare Corporation. 2023.
78. Baxter Healthcare Corporation. Forane (Isoflurane) Liquid for Inhalation [package insert]. Deerfield, IL: Baxter Healthcare Corporation. 2022.
79. Baxter Healthcare Corporation. Suprane (Desflurane) Liquid for Inhalation [package insert]. Deerfield, IL: Baxter Healthcare Corporation. 2023.
80. Barash, P. G., Cullen, B. F., Stoelting, R. K., Cahalan, M. K., Stock, M. C., Ortega, R., Sharar, S. R., & Holt, N. F. (2017). Clinical anesthesia (8th ed., pp. 469). Wolters Kluwer.